Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 72 EP applications Graham Robert Forrest has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11774431

PEPTIDE CONJUGATES OF GLP-1 RECEPTOR AGONISTS AND GASTRIN AND THEIR USE

IPC classification:
A61K 38/22, C07K 14/575, C07K 14/595, C07K 19/00
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11741514

GLUCAGON ANALOGUES

IPC classification:
A61K 38/26, A61P 5/48, C07K 14/605
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11776663

LOCAL COLOR MODIFICATION OF DYED FABRICS USING A LACCASE SYSTEM

IPC classification:
D06L 3/11, D06M 16/00, D06P 5/02, D06P 5/15
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12704117

COMBINATION OF ACYLATED GLUCAGON ANALOGUES WITH INSULIN ANALOGUES

IPC classification:
A61K 38/26, A61K 38/28, A61P 3/04, A61P 3/10
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12708470

ENZYME GRANULE BLENDS CONSISTING ESSENTIALLY OF SODIUM SULFATE

IPC classification:
A23K 1/165, C11D 3/386, C11D 17/06, C12N 9/98
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12711322

LACCASE VARIANTS HAVING INCREASED EXPRESSION AND/OR ACTIVITY

IPC classification:
C12N 9/02
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12720746

DETERGENT COMPOSITIONS CONTAINING BACILLUS SP. MANNANASE AND METHODS OF USE THEREOF

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12725903

USE OF CELLULASE AND GLUCOAMYLASE TO IMPROVE ETHANOL YIELDS FROM FERMENTATION

IPC classification:
C12P 7/06, C12P 19/14
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12720744

DETERGENT COMPOSITIONS CONTAINING BACILLUS AGARADHAERENS MANNANASE AND METHODS OF USE THEREOF

IPC classification:
A23K 1/00, A23L 1/00, C07K 14/195, C07K 14/435, C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12718871

DETERGENT COMPOSITIONS CONTAINING GEOBACILLUS TEPIDAMANS MANNANASE AND METHODS OF USE THEREOF

IPC classification:
A23K 1/165, A23L 1/00, C07K 14/195, C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12735601

METHODS FOR PREDICTING MAMMALIAN EMBRYO VIABILITY

IPC classification:
C12N 5/073, G01N 33/483, G01N 33/50
Applicant:
Cambridge Enterprise Ltd.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12830783

A PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING INTERFERON ALPHA CONJUGATE

IPC classification:
A61K 38/21, A61K 39/395, A61K 47/30, A61K 47/48, A61P 35/00
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12783582

GLP-1 RECEPTOR AGONIST PEPTIDE GASTRIN CONJUGATES

IPC classification:
A61K 47/48, A61P 3/10
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12845690

METHOD FOR PREPARING PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX

IPC classification:
C07K 1/18, C07K 17/08, C07K 17/10
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11796009

COMPOSITIONS COMPRISING SHIKIMIC ACID OBTAINED FROM OIL PALM BASED MATERIALS AND METHOD OF PRODUCING THEREOF

IPC classification:
C07C 62/32
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Agent:
Multiple attorneys, Maschio & Soames IP Limited
Agent:
John Scott Lloyd, Script IP Limited
Status:
GRANT OF PATENT INTENDED
EP12801247

A CONJUGATE COMPRISING OXYNTOMODULIN AND AN IMMUNOGLOBULIN FRAGMENT, AND USE THEREOF

IPC classification:
A61K 38/26, A61K 45/06, A61K 47/48, A61P 3/04, C07K 14/575, C07K 17/00
Agent:
Multiple attorneys, Boehmert & Boehmert Anwaltspartnerschaft mbB
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13704695

GLYCOSYLATION AS A STABILIZER FOR PHYTASE

IPC classification:
C12N 9/14
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13769126

A LIQUID FORMULATION OF HIGHLY CONCENTRATED LONG-ACTING HUMAN GROWTH HORMONE CONJUGATE

IPC classification:
A61K 9/08, A61K 38/18, A61K 38/22, A61K 38/27
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13716909

LOW TEMPERATURE METHOD FOR MAKING HIGH GLUCOSE SYRUP

IPC classification:
C12P 19/02, C12P 19/14, C13K 1/06
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13757286

PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

IPC classification:
A61K 38/16, A61K 38/17, A61P 1/16
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13721953

GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

IPC classification:
A61K 38/26, C07K 14/605
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13720931

GIP-GLP-1 DUAL AGONIST COMPOUNDS AND METHODS

IPC classification:
A61K 38/26, C07K 14/605, C12N 1/15, C12N 1/21
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13725613

ADENOVIRAL VECTORS FOR TRANSDUCTION OF VASCULAR TISSUE

IPC classification:
C12N 15/861
Applicant:
Crucell Holland B.V.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13740048

COLICINS FOR TREATING BACTERIAL INFECTIONS

IPC classification:
A23L 1/30, A61K 38/16, A61P 1/00, A61P 31/04
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
The patent has been granted
EP13756832

GLUCAGON ANALOGUES

IPC classification:
A61K 38/26, C07K 14/605, C12N 1/15, C12N 1/21, C12N 5/10
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13753013

TRICHODERMA REESEI GLUCOAMYLASE VARIANTS RESISTANT TO OXIDATION-RELATED ACTIVITY LOSS AND THE USE THEREOF

IPC classification:
A23L 1/09, C12N 9/34, C12P 19/14, C13K 1/06
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
The patent has been granted
EP13750251

METHOD OF USING ALPHA-AMYLASE FROM ASPERGILLUS CLAVATUS AND ISOAMYLASE FOR SACCHARIFICATION

IPC classification:
A23L 1/105, C11D 3/386, C12N 9/26, C12N 9/30, C12P 19/02, C12P 19/14
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13829413

MICROCAPSULE COMPOSITIONS AND METHODS

IPC classification:
A61K 9/50, A61K 9/52, C12P 19/34
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13765701

GLUCAGON ANALOGUES

IPC classification:
A61K 38/26, C07K 14/605
Applicant:
Boehringer Ingelheim International GmbH
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13811687

COMPOSITIONS AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13805709

COMPOSITIONS AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13811686

COMPOSITIONS AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13811709

METHOD OF USING ALPHA-AMYLASE FROM ASPERGILLUS FUMIGATUS AND ISOAMYLASE FOR SACCHARIFICATION

IPC classification:
A21D 8/04, A23L 1/105, C11D 3/386, C12C 11/00, C12N 9/28, C12P 7/06, C12P 19/14, D06M 16/00
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13862194

METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13814346

ALPHA-AMYLASE VARIANTS

IPC classification:
C11D 3/386, C12N 9/28
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13824233

NOVEL MANNANASE, COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14749595

POLYNUCLEOTIDE BARCODE GENERATION

IPC classification:
C40B 20/00, C40B 50/06
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15172588

PEPTIDES FOR PROMOTING ANGIOGENESIS AND AN USE THEREOF

IPC classification:
A61K 38/00, A61K 38/08, A61L 27/00, A61L 27/22, A61P 27/00, C07K 5/103, C07K 7/06
Applicant:
Samsung Life Public Welfare Foundation
Applicant:
Industry-Academic Cooperation Foundation, Sookmyun Women's University
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13150803

Skin or hair binding peptides

IPC classification:
A61K 8/64, A61Q 5/02, C07K 1/04, C07K 7/06, C07K 7/08, C12N 15/10
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12183920

Compositions and methods comprising variant microbial proteases

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12801439

A CIRCUMCISION DEVICE

IPC classification:
A61B 17/326
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Agent:
Script IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12183921

Compositions and methods comprising variant microbial proteases

IPC classification:
C12N 9/54, A23K 10/00
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15193733

COMPOSITIONS AND METHODS FOR INTRAMOLECULAR NUCLEIC ACID REARRANGEMENT

IPC classification:
C12N 15/10, C12N 15/66, C12Q 1/68
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Agent:
Williams Powell
Status:
EXAMINATION IN PROGRESS
EP15194914

PROTEASES COMPRISING ONE OR MORE COMBINABLE MUTATIONS

IPC classification:
C11D 3/386, C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14789589

MATERIALS AND METHODS FOR MODULATING DISC1 TURNOVER

IPC classification:
A61K 38/08, A61P 25/00, A61P 25/18, A61P 25/24, G01N 33/50
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14795564

ACYLATED GLUCAGON ANALOGUES

IPC classification:
A61K 38/26, C07K 14/605
Applicant:
Boehringer Ingelheim International GmbH
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14805199

GLUCAGON-GLP-1-GIP TRIPLE AGONIST COMPOUNDS

IPC classification:
C07K 14/435, C07K 14/575
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14812038

VARIANT ALPHA-AMYLASES HAVING REDUCED SUSCEPTIBILITY TO PROTEASE CLEAVAGE, AND METHODS OF USE, THEREOF

IPC classification:
C11D 3/386, C12N 9/26
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14815797

MATERIALS AND METHODS FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

IPC classification:
A61K 31/713, A61P 9/12, A61P 11/00, C12N 15/113, C12Q 1/68
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11704342

AMYLASE FROM NESTERENKONIA AND METHODS OF USE THEREOF

IPC classification:
C11D 3/16, C12N 9/28, C12N 15/55
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16171438

PEPTIDES FOR PROMOTING ANGIOGENESIS AND AN USE THEREOF

IPC classification:
A61K 38/00, A61K 38/07, A61K 38/08, A61P 9/00, A61P 17/02, C07K 5/10, C07K 7/06, C07K 11/00
Applicant:
Samsung Life Public Welfare Foundation
Applicant:
Industry-Academic Cooperation Foundation, Sookmyun Women's University
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16155927

COMPOSITIONS AND METHODS COMPRISING VARIANT MICROBIAL PROTEASES

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15706497

MATERIALS AND METHODS FOR MODULATION OF TENDON HEALING

IPC classification:
A61K 31/7088, C12N 15/113
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15740618

METHOD FOR SEPARATING TARGET ENTITIES FROM A SAMPLE USING A COMPOSITION OF MONO-SPECIFIC TETRAMERIC ANTIBODY COMPLEXES COUPLED TO A SURFACE

IPC classification:
B01D 37/02, C07K 1/22, C07K 16/28, C12N 1/00, C12N 5/07, C12N 5/078, C12N 5/0787, C12N 15/10, G01N 1/34, G01N 33/574
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15776968

FLUIDIC DEVICES, SYSTEMS, AND METHODS FOR ENCAPSULATING AND PARTITIONING REAGENTS, AND APPLICATIONS OF SAME

IPC classification:
B01L 3/00
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15728641

METHOD FOR PREVENTING OR TREATING MICROBIAL GROWTH ON A MANUFACTURED PRODUCT

IPC classification:
A01N 37/46, A01N 63/02
Applicant:
Stellenbosch University
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15812045

METHODS AND COMPOSITIONS FOR SAMPLE ANALYSIS

IPC classification:
C12Q 1/68
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15812053

ANALYSIS OF NUCLEIC ACID SEQUENCES

IPC classification:
C12N 15/10, C12Q 1/68, C40B 40/06
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16202774

COMPOSITIONS AND METHODS COMPRISING VARIANT MICROBIAL PROTEASES

IPC classification:
C12N 9/54
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP16200028

COMPOSITIONS AND METHODS COMPRISING PROTEASE VARIANTS

IPC classification:
C12N 9/52, C12N 9/64
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
The application has been published
EP15838102

SOLUBLE ANTIBODY COMPLEXES FOR T CELL OR NK CELL ACTIVATION AND EXPANSION

IPC classification:
A61K 39/00, A61P 37/02, C07K 16/28, C12N 5/0783
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15778548

COMPOSITIONS COMPRISING BETA MANNANASE AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15778848

COMPOSITIONS COMPRISING BETA-MANNANASE AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15778844

COMPOSITIONS COMPRISING BETA MANNANASE AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15778846

COMPOSITIONS COMPRISING BETA-MANNANASE AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15778556

COMPOSITIONS COMPRISING BETA MANNANASE AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15778845

COMPOSITIONS COMPRISING BETA-MANNANASE AND METHODS OF USE

IPC classification:
C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15767472

PULMONARY ADMINISTRATION OF PYOCINS FOR TREATING BACTERIAL RESPIRATORY INFECTIONS

IPC classification:
A61K 9/00, A61K 38/16, A61P 31/04, C07K 14/21
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15793990

METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID SEQUENCING

IPC classification:
C12Q 1/68
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP15795167

APPARATUS AND METHODS FOR ADMINISTERING A PHARMACEUTICAL AGENT

IPC classification:
A61B 5/00, A61B 5/145, A61M 5/142, A61M 5/145, A61M 5/172
Applicant:
Zealand Pharma A/S
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP16737637

PROCESSES AND SYSTEMS FOR PREPARING NUCLEIC ACID SEQUENCING LIBRARIES AND LIBRARIES PREPARED USING SAME

IPC classification:
B01J 19/00
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
Request for examination was made
EP17178273

NOVEL LONG-ACTING GLUCAGON CONJUGATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR THE PREVENTION AND TREATMENT OF OBESITY

IPC classification:
A61K 31/4164, A61K 38/26, A61P 3/00, A61P 3/04, C07K 14/605, A61K 47/68
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
The application has been published

Please Sign in to use this feature